| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/11/1994 | WO1994009781A1 Use of bhap compounds in combination with other non-nucleoside reverse transcriptase inhibitors for the treatment of hiv infection |
| 05/11/1994 | WO1994009780A1 Use of piperazine derivatives for the treatment of cognitive disorders |
| 05/11/1994 | WO1994009779A1 Soluble calcium lactate/quindonecarboxylic acids on naphthydrinecarboxylic acids complexes as non-irritating parenteral forms |
| 05/11/1994 | WO1994009778A1 Combinations of angiotensin-ii receptor antagonists and diuretics |
| 05/11/1994 | WO1994009777A1 Transdermal delivery of ketorolac |
| 05/11/1994 | WO1994009776A1 Adenosine diphosphoribose polymerase binding nitroso aromatic compounds useful as anti-retroviral agents and anti-tumor agents |
| 05/11/1994 | WO1994009772A1 Dithiocarbamates for the treatment of atherosclerosis and other cardiovascular and inflammatory diseases |
| 05/11/1994 | WO1994009771A1 Utilization of nitrovaso-dilators in the preparation of anti-inflammatory and analgesic medicaments of topical use |
| 05/11/1994 | WO1994009770A1 The use of aryl-, heteroaryl- and alkyltartronic acids as therapeutical agents |
| 05/11/1994 | WO1994009769A1 Use of choline in total parenteral nutrition |
| 05/11/1994 | WO1994009767A1 Novel use of pharmaceutical compositions |
| 05/11/1994 | WO1994009766A1 Inhibitors of farnesyl-protein transferase |
| 05/11/1994 | WO1994009765A1 Functional interactions between glial s-100b and central nervous system serotonergic neurons |
| 05/11/1994 | WO1994009764A1 Use of non steroidal anti estrogens for autoimmune diseases |
| 05/11/1994 | WO1994009763A1 Improvements relating to substituted isethionate surfactants and personal care compositions comprising said surfactants |
| 05/11/1994 | WO1994009762A1 Drug delivery device |
| 05/11/1994 | WO1994009761A1 Stable extended release oral dosage composition |
| 05/11/1994 | WO1994009755A1 Method and composition for prevention and/or treatment of dandruff and seborrhoeic dermatitis |
| 05/11/1994 | WO1994009753A1 Cosmetic deodorant preparations containing di- or triglycerin esters |
| 05/11/1994 | WO1994009650A1 Bifidobacterium growth promoter |
| 05/11/1994 | WO1994009625A2 Stabilization of fluorocarbon emulsions |
| 05/11/1994 | WO1994006402A3 Cosmetic or dermatologic composition containing at least one saponine of the ginsenoside type, and its applications particularly to hair care |
| 05/11/1994 | WO1994002107A3 Method and medicament for inhibiting neutrophil elastase and cathepsin g |
| 05/11/1994 | WO1994002103A3 Ovulation inhibitor for hormonal contraception |
| 05/11/1994 | EP0596802A1 Erythromycin derivatives, their process of preparation and their application as medicaments |
| 05/11/1994 | EP0596717A1 Nutritional supplement for the elderly |
| 05/11/1994 | EP0596631A2 Novel polymeric antimicrobials and their use in pharmaceutical compositions |
| 05/11/1994 | EP0596542A1 Therapeutic nucleosides |
| 05/11/1994 | EP0596541A1 New use of azatricyclo derivatives and pharmaceutical compositions containing them |
| 05/11/1994 | EP0596490A2 Stereoselective reduction of ketones |
| 05/11/1994 | EP0596449A2 Serotonin receptor antagonists for treating myocardial ischemia |
| 05/11/1994 | EP0596406A1 Imidazo (1,2-a) Pyridines as bradykinin antagonists |
| 05/11/1994 | EP0596326A1 Arylidene-1-azacycloalkanes and arylalkyl-1-azacycloalkanes, their salts, medicaments containing the same, use thereof and precesses for their production |
| 05/11/1994 | EP0596298A2 5-Spirosubstituted 1-H-3-aryl-pyrrolidin-2,4-dione derivatives as herbicides, insecticides and acaricides |
| 05/11/1994 | EP0596284A2 Antimycotic cosmetic and dermatological compositions containing fatty acid esters |
| 05/11/1994 | EP0596135A1 Lanolin fatty acids, separation thereof, and cosmetic and external preparation |
| 05/11/1994 | EP0596112A1 Novel macrolide compound and production thereof |
| 05/11/1994 | EP0596058A1 Biphenylylquinuclidine derivatives as squalene synthase inhibitors |
| 05/11/1994 | EP0596057A1 Quinuclidine derivatives as squalene synthase inhibitors |
| 05/11/1994 | EP0596049A1 Defoaming composition |
| 05/11/1994 | EP0595990A1 Novel 6-substituted steroids, methods for producing same and pharmaceutical compositions containing said steroids |
| 05/11/1994 | EP0595989A1 Benzopyrido piperylidene compounds, compositions, methods of manufacture and methods of use |
| 05/11/1994 | EP0595980A1 Benzodiazepine derivatives, compositions containing them and their use in therapy |
| 05/11/1994 | EP0595964A1 Process for the preparation of the optical isomers of a 2-aminonaphthyridine derivative |
| 05/11/1994 | EP0595924A1 Platelet activating factor antagonists |
| 05/11/1994 | EP0595910A1 S-(3-(4(5))-imidazolyl)propyl)isothiourea as selective trhistomine h3 receptor antagonist |
| 05/11/1994 | EP0595890A1 Antimicrobial treatment methods and compositions |
| 05/11/1994 | EP0595888A1 A process for the preparation of demethylepypodophyllotoxin. |
| 05/11/1994 | EP0595873A1 Cytosine deaminase negative selection system for gene transfer techniques and therapies |
| 05/11/1994 | EP0595854A1 Method of preparing a sterile-filterable solution of an active substance |
| 05/11/1994 | EP0595838A1 Tumor rejection antigen precursors, tumor rejection antigens and uses thereof |
| 05/11/1994 | EP0595826A1 2'-fluoro-2-substituted adeninyl arabinosides as anti-cancer agents |
| 05/11/1994 | EP0595796A1 Method of treatment of androgen-related diseases |
| 05/11/1994 | EP0463162B1 PREPARATION OF 5,6,7-TRINOR-4,8-INTER-m-PHENYLENE PGI 2 DERIVATIVES |
| 05/11/1994 | EP0440710B1 New antiviral agents |
| 05/11/1994 | EP0408668B1 Process for increasing phosphatidylcholine in vivo |
| 05/11/1994 | EP0399051B1 Polyvalent antiinflammatory agent |
| 05/11/1994 | EP0397689B1 Orthostatic lavage solutions |
| 05/11/1994 | EP0288563B1 Cyclic amine derivatives |
| 05/11/1994 | CN1086517A Novel 3-oxadiazolyl-1,6-naphthyridine derivatives |
| 05/11/1994 | CN1086515A Aryl group- or aromatic heterocyclic group-substituted aminoquinolone derivatives and anti-hiv agent |
| 05/11/1994 | CN1086512A Method for preparation of taxol |
| 05/11/1994 | CN1086422A Novel compositions containing hyaluronic acid associates and a process for preparing same |
| 05/11/1994 | CN1086421A Pharmaceutical composition inhibiting metastasis of cancer to liver and pharmaceutical composition treating liver cancer |
| 05/11/1994 | CA2448557A1 Multidrug resistance gene |
| 05/11/1994 | CA2148700A1 Piperidine derivatives as 5-ht4 receptor antagonists |
| 05/11/1994 | CA2148693A1 Tartronic acids, their acetalic ethers and o-esters |
| 05/11/1994 | CA2148620A1 Indolylcarbamates as anti-inflammatory agents |
| 05/11/1994 | CA2148455A1 Adenosine diphosphoribose polymerase binding nitroso aromatic compounds useful as anti-retroviral agents and anti-tumor agents |
| 05/11/1994 | CA2148368A1 Tnf-.alpha. ribozymes and degradation resistant mrna derivatives linked to tnf-.alpha. ribozymes |
| 05/11/1994 | CA2148357A1 Use of 17.alpha.-dihydroequilenin for lowering cholesterol |
| 05/11/1994 | CA2148258A1 Transcription factor dp-1 |
| 05/11/1994 | CA2148247A1 Rapamycin arylcarbonyl and alkoxycarbonyl as immunosuppressive and antifungal agents |
| 05/11/1994 | CA2148108A1 Ophthalmic solution and method of use |
| 05/11/1994 | CA2148003A1 Antimicrobial 5-hydrazino-quinolone derivatives |
| 05/11/1994 | CA2148002A1 1,2,3,5,6,7,8,8a-octahydro-5,5,8a-trimethyl-(8a.beta.)-6- isoquino lineamine derivatives, preparation method therefor and therapeutical usethereof |
| 05/11/1994 | CA2147866A1 Methods and compositions of (+) doxazosin for the treatment of benign prostatic hyperplasia and atherosclerosis |
| 05/11/1994 | CA2147862A1 Drug delivery device |
| 05/11/1994 | CA2147825A1 High purity beta-carotene |
| 05/11/1994 | CA2147609A1 Cephem compounds, and their pharmaceutical compositions |
| 05/11/1994 | CA2147605A1 Small molecule inhibition of rna/ligand binding |
| 05/11/1994 | CA2147509A1 Wavelength-specific photosensitive porphacyanine and expanded porphyrin-like compounds and methods for preparation and use thereof |
| 05/11/1994 | CA2147504A1 Substituted phthalazinones as neurotensin antagonists |
| 05/11/1994 | CA2147357A1 Methods and compositions (+) doxazosin for the treatment of hypertension |
| 05/11/1994 | CA2147241A1 Inhibitors of farnesyl-protein transferase |
| 05/11/1994 | CA2147240A1 Inhibitors of farnesyl-protein transferase |
| 05/11/1994 | CA2147129A1 New substituted azetidinones as anti-inflammatory and antidegenerative agents |
| 05/11/1994 | CA2146767A1 4-arylmethyloxymethyl piperidines as tachykinin antagonists |
| 05/11/1994 | CA2146651A1 4-quinolinyl derivatives with anti-helicobacter activity |
| 05/11/1994 | CA2146019A1 Dopamine receptor subtype ligands |
| 05/11/1994 | CA2146018A1 Dopamine receptor subtype ligands |
| 05/11/1994 | CA2145545A1 "sensitizing hiv-1 inhibitors" sensitize hiv infected individuals to "non-nucleoside hiv treatment drugs" |
| 05/11/1994 | CA2144652A1 Soluble calcium lactate antibacterial complexes as non-irritating parenteral forms |
| 05/11/1994 | CA2144161A1 Novel vitamin d analogues |
| 05/11/1994 | CA2143191A1 Sulfonylalkanoylamino hydroxyethylamino sulfamic acids useful as retroviral protease inhibitors |
| 05/11/1994 | CA2142997A1 Hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors |
| 05/11/1994 | CA2136076A1 Aryl and heteroarylmethoxyphenyl inhibitors of leukotriene biosynthesis |
| 05/11/1994 | CA2127123A1 Benzenesulfonamide derivatives |
| 05/11/1994 | CA2104060A1 Aryl-fused and hetaryl-fused-2,4-diazepine and 2,4-diazocine antiarrhythmic agents |
| 05/10/1994 | US5310959 Reacting 1-decyne with 1,4-dihalo-2-butyne using a strong base and then reacting with 5-hexynoic acid; reacting with an amine in the presense of carbonyldiimidazole to amidate |